Multiple Assemblies exist for SMTL entry 8gb5
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9; X-RAY DIFFRACTION 3.35 Å

	SMTL ID 8gb5.1 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION; BICINE Polypeptides Spike protein S1; 25F9 Heavy chain; 25F9 Light chain Oligo-state hetero-1-1-1-mer
	SMTL ID 8gb5.2 Ligands alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION; BICINE Polypeptides Spike protein S1; 25F9 Light chain; 25F9 Heavy chain Oligo-state hetero-1-1-1-mer
	SMTL ID 8gb5.3 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose; BICINE; SULFATE ION Polypeptides Spike protein S1; 25F9 Light chain; 25F9 Heavy chain Oligo-state hetero-1-1-1-mer
	SMTL ID 8gb5.4 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose; SULFATE ION; GLYCEROL Polypeptides Spike protein S1; 25F9 Light chain; 25F9 Heavy chain Oligo-state hetero-1-1-1-mer